middle.news
4DMedical’s CT:VQ™ Wins FDA Nod, Poised to Disrupt Lung Imaging Market
8:35am on Monday 1st of September, 2025 AEST
•
Healthcare
Read Story
4DMedical’s CT:VQ™ Wins FDA Nod, Poised to Disrupt Lung Imaging Market
8:35am on Monday 1st of September, 2025 AEST
Key Points
FDA 510(k) clearance granted for CT – VQ™
CT – VQ™ offers non-contrast, radiotracer-free lung imaging
Initial U.S. market opportunity exceeds USD 1.1 billion
Clinical validation shows equivalence to gold-standard nuclear VQ scans
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
4DX
OPEN ARTICLE